CSIMarket


Flexion Therapeutics Inc   (FLXN)
Other Ticker:  
 


 

Flexion Therapeutics Inc

FLXN's Financial Statements and Analysis



Flexion Therapeutics Inc increased third quarter of 2021 net loss per share of $-0.60 compare to net loss per share of $-0.50 recorded in the same quarter a year ago a decrease compare to $-0.44 realized in previous quarter.


third quarter of 2021
Earnings Per Share Revenues
$ -0.6 $  21 Mill
$-0.10     $-2M     -9.88 %



Flexion Therapeutics Inc 's Revenue fell by -9.88 % in third quarter of 2021 (Sep 30 2021) year on year, to $21 million and declined by -24.31 % sequentially.


Flexion Therapeutics Inc is

More on FLXN's Income Statement



Flexion Therapeutics Inc 's in thethird quarter of 2021 recorded net loss of $-30.312 million, an increase from net loss of $-24.638 million in III. Quarter a year ago.

Sequentially net loss advanced

More on FLXN's Growth

Flexion Therapeutics Inc Inventories
Inventories declined by -18.29 % to $14.67 million from III. Quarter a year ago, sequentially inventories rose by 19.25 %. FLXN's Cash flow In the third quarter of 2021 company's net cash flow was $29 million, capital expenditures grew by -3.322-85.79%, to $0 millions compare to same quarter a year ago

More on FLXN's Cash flow Statement


Flexion Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Flexion Therapeutics Inc payed $ -1.22 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -1.64 per share from $ -1.12.

Company issued 0.30 million shares or 0.59 % in Sep 30 2021.


More on FLXN's Dividends

 Market Capitalization (Millions) 458
 Shares Outstanding (Millions) 50
 Total Debt (Millions $) 251
 Revenue (TTM) (Millions $) 100
 Net Income (TTM) (Millions $) -101
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 215




Flexion Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Flexion Therapeutics Inc had negative $ -1.22 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -1.64 per share from $ -1.12.

Company issued 0.30 million shares or 0.59 % in Sep 30 2021.


More on FLXN's Balance Sheets

 Market Capitalization (Millions) 458
 Shares Outstanding (Millions) 50
 Total Debt (Millions $) 251
 Revenue (TTM) (Millions $) 100
 Net Income (TTM) (Millions $) -101
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 215
   



Date modified: 2023-03-24T05:35:23+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com